Increasing calcium intake does not reduce further fracture risk

Article

Consuming more than 700 mg of calcium per day in later years does not further reduce the risk of fracture or osteoporosis and may, in fact, increase the risk for hip fractures, according to new research.

Consuming more than 700 mg of calcium per day in later years does not further reduce the risk for fracture or osteoporosis and may, in fact, increase the risk for hip fracture, according to the findings of a large longitudinal and prospective cohort study from Sweden. The study involved more than 61,000 women between 63 and 97 years of age participating in the Swedish Mammography Cohort, established in 1987. Of these, about 5,000 women participated in a subcohort.

During 19 years of follow-up, almost 15,000 women, or just about one-quarter, experienced some type of first fracture. Among those, 6% (3,871) experienced a first hip fracture. Among the women in the subcohort, 20% met the criteria for osteoporosis. The researchers found that the risk patterns associated with dietary calcium intake were nonlinear. They calculated that the rate of a first fracture of any type among women in the first quintile of calcium intake (less than 751 mg per day) was 17.2 per 1,000 person-years at risk; for those in the second quintile (751 to 882 mg per day), the third quintile (882 to 996 mg per day), the fourth quintile (996 to 1,137 mg per day), and the fifth quintile (greater than 1,137 mg per day), the rates were 14.7 (14.2 to 15.3), 14.0 (13.5 to 14.5), 14.1 (13.6 to 14.7), and 14.0 (13.5 to 14.5), respectively.

Those in the lowest quintile were at highest risk for a first hip fracture, with an adjusted hazard ratio (HR) of 1.29 (1.17 to 1.43), but the group at next highest risk for hip fracture was the fifth quintile, with an adjusted HR for hip fracture of 1.19 (1.06 to 1.32). A low vitamin D intake made the rate of fracture in the first calcium quintile even more pronounced. Adjusted odds ratios for osteoporosis from the first to the fifth quintiles were as follows: 1.47 (1.09 to 2.00); 1.26 (0.99 to 1.60); 1.0 (reference); 0.92 (0.74 to 1.15); and 1.01 (0.81 to 1.27).

Recent Videos
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jihong Liu, ScD, explains how to improve perinatal outcomes in COVID patients | Image Credit: sc.edu.
1 expert is featured in this series.
Jihong Liu, ScD, highlights adverse perinatal outcomes linked to the COVID pandemic | Image Credit: sc.edu.
Experts highlight infant health benefits from minor diet changes in pregnancy | Image Credit: ohsu.edu.
Connie Stark, RNC, PNC, provides fertility preservation insights for endometriosis patients | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.